Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

833 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
YES1 as a Therapeutic Target for HER2-Positive Breast Cancer after Trastuzumab and Trastuzumab-Emtansine (T-DM1) Resistance Development.
Fujihara M, Shien T, Shien K, Suzawa K, Takeda T, Zhu Y, Mamori T, Otani Y, Yoshioka R, Uno M, Suzuki Y, Abe Y, Hatono M, Tsukioki T, Takahashi Y, Kochi M, Iwamoto T, Taira N, Doihara H, Toyooka S. Fujihara M, et al. Among authors: otani y. Int J Mol Sci. 2021 Nov 26;22(23):12809. doi: 10.3390/ijms222312809. Int J Mol Sci. 2021. PMID: 34884609 Free PMC article.
The role of C1orf50 in breast cancer progression and prognosis.
Otani Y, Tanaka A, Maekawa M, Peña T, Rogachevskaya A, Ando T, Itano T, Katayama H, Nakata E, Ozaki T, Toyooka S, Doihara H, Roehrl MH, Fujimura A. Otani Y, et al. Breast Cancer. 2024 Nov 28. doi: 10.1007/s12282-024-01653-8. Online ahead of print. Breast Cancer. 2024. PMID: 39604563
833 results